LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Sample adequacy controls for infectious disease diagnosis by oral swabbing.

    Deviaene, Meagan / Weigel, Kris M / Wood, Rachel C / Luabeya, Angelique K K / Jones-Engel, Lisa / Hatherill, Mark / Cangelosi, Gerard A

    PloS one

    2020  Volume 15, Issue 10, Page(s) e0241542

    Abstract: Oral swabs are emerging as a non-invasive sample type for diagnosing infectious diseases including Ebola, tuberculosis (TB), and COVID-19. To assure proper sample collection, sample adequacy controls (SACs) are needed that detect substances indicative of ...

    Abstract Oral swabs are emerging as a non-invasive sample type for diagnosing infectious diseases including Ebola, tuberculosis (TB), and COVID-19. To assure proper sample collection, sample adequacy controls (SACs) are needed that detect substances indicative of samples collected within the oral cavity. This study evaluated two candidate SACs for this purpose. One detected representative oral microbiota (Streptococcus species DNA) and the other, human cells (human mitochondrial DNA, mtDNA). Quantitative PCR (qPCR) assays for the two target cell types were applied to buccal swabs (representing samples collected within the oral cavity) and hand swabs (representing improperly collected samples) obtained from 51 healthy U.S. volunteers. Quantification cycle (Cq) cutoffs that maximized Youden's index were established for each assay. The streptococcal target at a Cq cutoff of ≤34.9 had 99.0% sensitivity and specificity for oral swab samples, whereas human mtDNA perfectly distinguished between hand and mouth swabs with a Cq cutoff of 31.3. The human mtDNA test was then applied to buccal, tongue, and gum swabs that had previously been collected from TB patients and controls in South Africa, along with "air swabs" collected as negative controls (total N = 292 swabs from 71 subjects). Of these swabs, 287/292 (98%) exhibited the expected Cq values. In a paired analysis the three oral sites yielded indistinguishable amounts of human mtDNA, however PurFlockTM swabs collected slightly more human mtDNA than did OmniSwabsTM (p = 0.012). The results indicate that quantification of human mtDNA cannot distinguish swabs collected from different sites within the mouth. However, it can reliably distinguish oral swabs from swabs that were not used orally, which makes it a useful SAC for oral swab-based diagnosis.
    MeSH term(s) Adult ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/transmission ; COVID-19/virology ; COVID-19 Testing/methods ; DNA, Mitochondrial/analysis ; DNA, Mitochondrial/genetics ; DNA, Viral/analysis ; DNA, Viral/genetics ; Diagnostic Tests, Routine/methods ; Female ; Humans ; Male ; Mouth/virology ; Real-Time Polymerase Chain Reaction ; Reference Standards ; SARS-CoV-2/isolation & purification ; Sensitivity and Specificity ; South Africa/epidemiology ; Specimen Handling/methods ; Washington/epidemiology
    Chemical Substances DNA, Mitochondrial ; DNA, Viral
    Keywords covid19
    Language English
    Publishing date 2020-10-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0241542
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Molecular Detection of Airborne

    Bunyasi, Erick W / Middelkoop, Keren / Koch, Anastasia / Hoosen, Zeenat / Mulenga, Humphrey / Luabeya, Angelique K K / Shenje, Justin / Mendelsohn, Simon C / Tameris, Michele / Scriba, Thomas J / Warner, Digby F / Wood, Robin / Andrews, Jason R / Hatherill, Mark

    American journal of respiratory and critical care medicine

    2021  Volume 205, Issue 3, Page(s) 350–356

    Abstract: Rationale: ...

    Abstract Rationale:
    MeSH term(s) Adolescent ; Air Microbiology ; Cross-Sectional Studies ; DNA, Bacterial/analysis ; Female ; Humans ; Inhalation Exposure/adverse effects ; Inhalation Exposure/analysis ; Inhalation Exposure/statistics & numerical data ; Male ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/isolation & purification ; Risk ; Schools ; South Africa ; Tuberculosis/diagnosis ; Tuberculosis/transmission
    Chemical Substances DNA, Bacterial
    Language English
    Publishing date 2021-11-09
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202102-0405OC
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Regional changes in tuberculosis disease burden among adolescents in South Africa (2005-2015).

    Bunyasi, Erick Wekesa / Mulenga, Humphrey / Luabeya, Angelique K K / Shenje, Justin / Mendelsohn, Simon C / Nemes, Elisa / Tameris, Michele / Wood, Robin / Scriba, Thomas J / Hatherill, Mark

    PloS one

    2020  Volume 15, Issue 7, Page(s) e0235206

    Abstract: Background: Adolescents in the Western Cape Province of South Africa had high force of Mycobacterium tuberculosis (MTB) infection (14% per annum) and high TB incidence (710 per 100,000 person-years) in 2005. We describe subsequent temporal changes in ... ...

    Abstract Background: Adolescents in the Western Cape Province of South Africa had high force of Mycobacterium tuberculosis (MTB) infection (14% per annum) and high TB incidence (710 per 100,000 person-years) in 2005. We describe subsequent temporal changes in adolescent TB disease notification rates for the decade 2005-2015.
    Method: We conducted an analysis of patient-level adolescent (age 10-19 years) TB disease data, obtained from an electronic TB register in the Breede Valley sub-district, Western Cape Province, South Africa, for 2005-2015. Numerators were annual TB notifications (HIV-related and HIV-unrelated); denominators were mid-year population estimates. Period averages of TB rates were obtained using time series modeling. Temporal trends in TB rates were explored using the Mann-Kendall test.
    Findings: The average adolescent TB disease notification rate was 477 per 100,000 for all TB patients (all-TB) and 361 per 100,000 for microbiologically-confirmed patients. The adolescent all-TB rate declined by 45% from 662 to 361 per 100,000 and the microbiologically-confirmed TB rate by 38% from 492 to 305 per 100,000 between 2005-2015, driven mainly by rapid decreases for the period 2005-2009. There was a statistically significant negative temporal trend in both all-TB (per 100,000) (declined by 48%; from 662 to 343; p = 0·028) and microbiologically confirmed TB (per 100,000) (declined by 49%; from 492 to 252; p = 0·027) for 2005-2009, which was not observed for the period 2009-2015 (rose 5%; from 343 to 361; p = 0·764 and rose 21%; from 252 to 305; p = 1·000, respectively).
    Interpretation: We observed an encouraging fall in adolescent TB disease rates between 2005-2009 with a subsequent plateau during 2010-2015, suggesting that additional interventions are needed to sustain initial advances in TB control.
    MeSH term(s) Adolescent ; Age Factors ; Disease Notification ; Female ; Humans ; Incidence ; Male ; Mycobacterium tuberculosis/isolation & purification ; South Africa/epidemiology ; Tuberculosis/epidemiology
    Keywords covid19
    Language English
    Publishing date 2020-07-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0235206
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Sample adequacy controls for infectious disease diagnosis by oral swabbing

    Deviaene, Meagan / Weigel, Kris M / Wood, Rachel C / Luabeya, Angelique K K / Jones-Engel, Lisa / Hatherill, Mark / Cangelosi, Gerard A

    PLoS One

    Abstract: Oral swabs are emerging as a non-invasive sample type for diagnosing infectious diseases including Ebola, tuberculosis (TB), and COVID-19. To assure proper sample collection, sample adequacy controls (SACs) are needed that detect substances indicative of ...

    Abstract Oral swabs are emerging as a non-invasive sample type for diagnosing infectious diseases including Ebola, tuberculosis (TB), and COVID-19. To assure proper sample collection, sample adequacy controls (SACs) are needed that detect substances indicative of samples collected within the oral cavity. This study evaluated two candidate SACs for this purpose. One detected representative oral microbiota (Streptococcus species DNA) and the other, human cells (human mitochondrial DNA, mtDNA). Quantitative PCR (qPCR) assays for the two target cell types were applied to buccal swabs (representing samples collected within the oral cavity) and hand swabs (representing improperly collected samples) obtained from 51 healthy U.S. volunteers. Quantification cycle (Cq) cutoffs that maximized Youden's index were established for each assay. The streptococcal target at a Cq cutoff of ≤34.9 had 99.0% sensitivity and specificity for oral swab samples, whereas human mtDNA perfectly distinguished between hand and mouth swabs with a Cq cutoff of 31.3. The human mtDNA test was then applied to buccal, tongue, and gum swabs that had previously been collected from TB patients and controls in South Africa, along with "air swabs" collected as negative controls (total N = 292 swabs from 71 subjects). Of these swabs, 287/292 (98%) exhibited the expected Cq values. In a paired analysis the three oral sites yielded indistinguishable amounts of human mtDNA, however PurFlockTM swabs collected slightly more human mtDNA than did OmniSwabsTM (p = 0.012). The results indicate that quantification of human mtDNA cannot distinguish swabs collected from different sites within the mouth. However, it can reliably distinguish oral swabs from swabs that were not used orally, which makes it a useful SAC for oral swab-based diagnosis.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #895083
    Database COVID19

    Kategorien

  5. Article: Regional changes in tuberculosis disease burden among adolescents in South Africa (2005-2015)

    Bunyasi, Erick Wekesa / Mulenga, Humphrey / Luabeya, Angelique K K / Shenje, Justin / Mendelsohn, Simon C / Nemes, Elisa / Tameris, Michele / Wood, Robin / Scriba, Thomas J / Hatherill, Mark

    PLoS One

    Abstract: BACKGROUND: Adolescents in the Western Cape Province of South Africa had high force of Mycobacterium tuberculosis (MTB) infection (14% per annum) and high TB incidence (710 per 100,000 person-years) in 2005. We describe subsequent temporal changes in ... ...

    Abstract BACKGROUND: Adolescents in the Western Cape Province of South Africa had high force of Mycobacterium tuberculosis (MTB) infection (14% per annum) and high TB incidence (710 per 100,000 person-years) in 2005. We describe subsequent temporal changes in adolescent TB disease notification rates for the decade 2005-2015. METHOD: We conducted an analysis of patient-level adolescent (age 10-19 years) TB disease data, obtained from an electronic TB register in the Breede Valley sub-district, Western Cape Province, South Africa, for 2005-2015. Numerators were annual TB notifications (HIV-related and HIV-unrelated); denominators were mid-year population estimates. Period averages of TB rates were obtained using time series modeling. Temporal trends in TB rates were explored using the Mann-Kendall test. FINDINGS: The average adolescent TB disease notification rate was 477 per 100,000 for all TB patients (all-TB) and 361 per 100,000 for microbiologically-confirmed patients. The adolescent all-TB rate declined by 45% from 662 to 361 per 100,000 and the microbiologically-confirmed TB rate by 38% from 492 to 305 per 100,000 between 2005-2015, driven mainly by rapid decreases for the period 2005-2009. There was a statistically significant negative temporal trend in both all-TB (per 100,000) (declined by 48%; from 662 to 343; p = 0·028) and microbiologically confirmed TB (per 100,000) (declined by 49%; from 492 to 252; p = 0·027) for 2005-2009, which was not observed for the period 2009-2015 (rose 5%; from 343 to 361; p = 0·764 and rose 21%; from 252 to 305; p = 1·000, respectively). INTERPRETATION: We observed an encouraging fall in adolescent TB disease rates between 2005-2009 with a subsequent plateau during 2010-2015, suggesting that additional interventions are needed to sustain initial advances in TB control.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #32609738
    Database COVID19

    Kategorien

  6. Article ; Online: Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.

    Tameris, Michele / McShane, Helen / McClain, J Bruce / Landry, Bernard / Lockhart, Stephen / Luabeya, Angelique K K / Geldenhuys, Hennie / Shea, Jacqui / Hussey, Gregory / van der Merwe, Linda / de Kock, Marwou / Scriba, Thomas / Walker, Robert / Hanekom, Willem / Hatherill, Mark / Mahomed, Hassan

    Tuberculosis (Edinburgh, Scotland)

    2013  Volume 93, Issue 2, Page(s) 143–149

    Abstract: Background: New tuberculosis (TB) vaccines are being developed to combat the global epidemic. A phase IIb trial of a candidate vaccine, MVA85A, was conducted in a high burden setting in South Africa to evaluate proof-of-concept efficacy for prevention ... ...

    Abstract Background: New tuberculosis (TB) vaccines are being developed to combat the global epidemic. A phase IIb trial of a candidate vaccine, MVA85A, was conducted in a high burden setting in South Africa to evaluate proof-of-concept efficacy for prevention of TB in infants.
    Objective: To describe the study design and implementation lessons from an infant TB vaccine efficacy trial.
    Methods: This was a randomised, controlled, double-blind clinical trial comparing the safety and efficacy of MVA85A to Candin control administered to 4-6-month-old, BCG-vaccinated, HIV-negative infants at a rural site in South Africa. Infants were followed up for 15-39 months for incident TB disease based on pre-specified endpoints.
    Results: 2797 infants were enrolled over 22 months. Factors adversely affecting recruitment and the solutions that were implemented are discussed. Slow case accrual led to six months extension of trial follow up.
    Conclusion: The clinical, regulatory and research environment for modern efficacy trials of new TB vaccines are substantially different to that when BCG vaccine was first evaluated in infants. Future infant TB vaccine trials will need to allocate sufficient resources and optimise operational efficiency. A stringent TB case definition is necessary to maximize specificity, and TB case accrual must be monitored closely.
    MeSH term(s) BCG Vaccine ; Double-Blind Method ; Follow-Up Studies ; Humans ; Infant ; Patient Selection ; Research Design ; South Africa/epidemiology ; Treatment Outcome ; Tuberculosis/diagnosis ; Tuberculosis/epidemiology ; Tuberculosis/prevention & control ; Tuberculosis Vaccines ; Vaccines, Attenuated ; Vaccines, DNA ; Viral Vaccines
    Chemical Substances BCG Vaccine ; MVA 85A ; Tuberculosis Vaccines ; Vaccines, Attenuated ; Vaccines, DNA ; Viral Vaccines
    Language English
    Publishing date 2013-02-12
    Publishing country Scotland
    Document type Clinical Trial, Phase II ; Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2046804-0
    ISSN 1873-281X ; 1472-9792
    ISSN (online) 1873-281X
    ISSN 1472-9792
    DOI 10.1016/j.tube.2013.01.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top